News From The Annual New York Aesthetic and Plastic Surgery Meeting
RadioFrequency Devices for facial tightening and lifting surpass Ulthera technology as well as other similar devices.
EVOLASTIN, the new aesthetic device developed by the companies Syneron/Candela can achieve not only tightening, but also volumizing. This new technology delivers fractional bipolar energy via microneedling directly into the dermis. Delivery of energy into the dermis has been the problem with most other devices. By placing these very thin needles 1-2 mm into the dermis, allowing for very targeted deposition of heat, there is finally a solution. As a result, the skin will naturally produce collagen, elastin and hyaluronic acid.
None of the devices currently on the market can promise volumizing of targeted skin. Thermage and Ulthera, some of the most publicized devices, achieve tightening at best. The results are however not consistent and neither is patient satisfaction.
HAIR TRANSPLANTATION another area, which I have been investigating, is now available without surgery. A new automated device NeoGraft allows harvesting of donor hair via the follicular unit extraction (FUE) technique. It is a noninvasive procedure, with reduced complications, which provides the patient with a very natural looking outcome and no unsightly linear scar.
This procedure begins by using a small cannula to extract the follicular units from the patients’ resistant donor areas, generally from the back of the head where the hair is thicker, stronger and genetically programmed to continue to grow. The harvested hairs are then transplanted into the patient’s balding areas. When done by hand the FUE technique is limited to only 500-700 grafts per session. With the NeoGraft system we can average 2000 follicles per session.
This is the most advanced technique in the hair transplantation industry.
A new supplement has emerged to prevent cellular death: TA-65MD. This new product was developed after the breakthrough research of Dr. Blackburn and her team, who were awarded the NOBEL PRIZE in Medicine in 2009.
Early genetic research showed that shortening of telomeres (end caps which protect the chromosomes) leads to cell death. The enzyme telomerase protects telomeres and thus prevents cell loss. Unfortunately with age, the levels of this enzyme decrease.
Every effect of the aging process is connected to telomere shortening. Compromised cellular function begins even before the telomeres are shortened.
TA-65MD is obtained from a natural plant called Astragalus, a known medicinal plant used by the Chinese for over 2,000 years.
TA-65MD is proven to:
- Activate Telomerase
- Lengthen Short Telomeres
- Restore the Immune System
- Increase Bone Density
- Promotes Cardiovascular Health and Hormonal Balance
Other reported benefits:
- Increased Energy
- Improved Endurance
- Vision Improvements
- Enhanced Libido
- Better Skin Elasticity
We are presently investigating these technologies to bring you the latest and most efficient treatments. Keep following us on Facebook, Twitter and check our website for updates. You can share the exciting news with your friends and colleagues.
For any additional information you can contact us via email at firstname.lastname@example.org or by phone at 9147303333.